Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks.

Begasse de Dhaem, Olivia; Takizawa, Tsubasa; Dodick, David W

Begasse de Dhaem, Olivia; Takizawa, Tsubasa; Dodick, David W.

Afiliação

Begasse de Dhaem O; Hartford HealthCare, Neurology Department, University of Connecticut, Milford, CT, USA.
Takizawa T; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Dodick DW; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.

Cephalalgia ; 43(2): 3331024221137092, 2023 02.

Article em En | MEDLINE | ID: mdl-36739505

Assuntos

Transtornos de Enxaqueca; Humanos; Alanina Transaminase; Transtornos de Enxaqueca/tratamento farmacológico; Aspartato Aminotransferases

Palavras-chave

Ditan; efficacy; function; gepant; safety; tolerability

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google